Shanghai HEP Pharmaceatical Co., Ltd.   Report issue

For profit Phase 2
Founded: Shanghai China (2005)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2015
NCT02612506
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shanghai HEP Pharmaceatical Co., Ltd.